Resources>Blog>Immunofluorescence

Immunofluorescence

Biointron 2024-01-20 Read time: 2 mins
Principle-for-direct-and-indirect-immunofluorescence-assay-Figure.jpg
Image credit: DOI: 10.3384/diss.diva-170740

Immunofluorescence (IF) is an immunochemical staining technique that utilizes fluorochrome-labeled antibodies for the visualization and localization of targets, by labelling with a fluorescent dye such as fluorescein isothiocyanate (FITC). It can identify a wide range of components on tissue sections, cultured cells, or individual cells, and is thus highly valuable for their broad capability with the use of combinations of specific antibodies tagged with fluorophores.

There are several steps for IF, with the first being fixation to immobilize target antigens while maintaining cellular architecture. Next, sample preparation and blocking needs to be carried out to prevent non-specific binding of antibodies. Then, incubation of primary and secondary antibodies take place before the final preservation and imaging.

There are two different IF methods available: Direct (Primary) and Indirect (Secondary). Direct detection requires using a single fluorochrome-conjugated primary antibody. Meanwhile, indirect detection uses two antibodies, with the first being an unlabeled primary antibody, followed by a fluorochrome-conjugated secondary antibody.

Although both monoclonal and polyclonal antibodies can be used for IF, they have their own pros and cons. Indirect IF more commonly used as the secondary antibodies are typically polyclonal, allowing for the recognition of multiple epitopes of the targets. However, monoclonal antibodies which are specifically designed for IF may be more preferable if your research involves recognizing very specific targets.1

At Biointron, we are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.


References:

  1. Im, K., Mareninov, S., Diaz, M. F. P., & Yong, W. H. (2019). An introduction to Performing Immunofluorescence Staining. Methods in Molecular Biology (Clifton, N.J.), 1897, 299. https://doi.org/10.1007/978-1-4939-8935-5_26

Subscribe to our Blog

Recommended Articles

Immune-Stimulating Antibody Conjugates (ISACs): Challenges and Future Prospects

Antibody-drug conjugates (ADCs) have transformed cancer therapy by selectively d……

Mar 14, 2025
A Global Overview of Therapeutic Antibody Development

Monoclonal antibodies (mAbs) have significantly improved the treatment landscape……

Mar 12, 2025
World ADC 2025 – London: Highlights and Event Recap

The 15th World ADC London was held on March 3-6, 2025. Antibody-drug conjugates ……

Mar 10, 2025
Antibody CRO Services: Advancing Antibody Discovery & Production

Discover leading antibody CRO services for therapeutic and diagnostic applicatio……

Mar 06, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.